Shenzhen Cavlon Technology to Showcase Red Light Therapy Products at FIME 2024

Shenzhen Cavlon Technology Co., Ltd., a leading developer and manufacturer of red light therapy and infrared therapy devices, it is exhibiting at the FIME Medical Expo, taking place June 19-21, 2024, at the Miami Beach Convention Center (Booth #V91).

Shenzhen Cavlon Technology has been a leading provider of rehabilitation medical equipment for over 15 years. They specialize in red light therapy (RLT) and infrared therapy devices designed for home use and professional settings. Their products are used in hospitals, clinics, pharmacies, rehabilitation centers, beauty salons, and traditional Chinese medicine centers.

We are excited to showcase our innovative line of red light therapy and infrared therapy devices at FIME 2024. Our products are backed by years of research and development, and they are designed to provide safe and effective treatment for a variety of conditions.

Shenzhen Cavlon Technology’s Erray series of red light therapy devices have been cleared by the US Food and Drug Administration (FDA) as Class II medical devices. They have also received CE certification for the European Union and meet FCC and Rohs standards.

At FIME 2024, Shenzhen Cavlon Technology will be demonstrating their latest Erray series products, including devices for hair regeneration, skin whitening, improving blood circulation, and joint pain treatment.

About Shenzhen Cavlon Technology Co., Ltd.

Shenzhen Cavlon Technology Co., Ltd. is a national high-tech enterprise focused on the research, development, production, and sales of rehabilitation medical equipment. The company has an independent R&D team with years of experience in developing red light therapy and infrared therapy devices. Shenzhen Cavlon Technology is committed to providing high-quality medical devices and OEM/ODM customized services for domestic and foreign customers.

Related News
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept